AcquisitionsMay 7, 2026, 04:06 PM
Catalyst Pharma Cancels Q1 Earnings Call Due to Pending Acquisition
AI Summary
Catalyst Pharmaceuticals has cancelled its first quarter 2026 earnings conference call and webcast, which was previously scheduled for May 12, 2026. This decision was made in light of the pending acquisition of Catalyst by Angelini Pharma S.p.A., which was announced today. The company still plans to release its first quarter 2026 financial results after market close on Monday, May 11, 2026, as originally scheduled.
Key Highlights
- Catalyst Pharmaceuticals cancelled its Q1 2026 earnings conference call and webcast.
- The cancellation is due to the pending acquisition by Angelini Pharma S.p.A.
- Catalyst will still release its Q1 2026 financial results after market close on Monday, May 11, 2026.
Price Impact
More from CPRX